Leaflet: information for the user
Rocoz Prolong 50 mg prolonged-release tablets EFG
Rocoz Prolong 150 mg prolonged-release tablets EFG
Rocoz Prolong 200 mg prolonged-release tablets EFG
Rocoz Prolong 300 mg prolonged-release tablets EFG
Rocoz Prolong 400 mg prolonged-release tablets EFG
Quetiapina
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
1. What isRocoz Prolongand what it is used for
2. What you need to know before starting to takeRocoz Prolong
3. How to takeRocoz Prolong
4. Possible side effects
5. Storage ofRocoz Prolong
6. Contents of the pack and additional information
Rocoz Prolong contains a substance called quetiapina. It belongs to a group of medications called antipsicotics. Rocoz Prolong can be used to treat several diseases, such as:
When using Rocoz Prolong to treat major depressive episodes in major depressive disorder, this will be taken in addition to another medication that is being used to treat this disease.
Your doctor may continue prescribing Rocoz Prolong even when you are feeling better.
Do not take Rocoz Prolong:
If you are unsure, consult your doctor or pharmacist before taking this medicine.
Warnings and precautions
Consult your doctor or pharmacist before starting to take quetiapine:
Inform your doctor immediately if after taking quetiapine you experience any of the following:
These conditions may be caused by this type of medicine.
Inform your doctor as soon as possible if you have:
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medicines take time to have an effect, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Severe skin reactions (SCARs)
Very rarely, severe skin reactions (SCARs) have been reported with the use of this medicine, which may put your life at risk or be fatal. These usually manifest as:
•Stevens-Johnson syndrome (SSJ), a generalised rash with blisters and peeling of the skin, particularly around the mouth, nose, eyes, and genitals.
•Toxic epidermal necrolysis (TEN), a more severe form that causes extensive peeling of the skin.
•Drug reaction with eosinophilia and systemic symptoms (DRESS), which consists of flu-like symptoms with a rash, fever, swollen lymph nodes, and abnormal blood test results (including an increase in white blood cell count (eosinophilia) and elevated liver enzymes).
•Generalized Acute Exanthematous Pustulosis (AGEP), small pus-filled blisters.
•Multi-form erythema (EM), skin rashes with irregular red patches that itch.
If you develop these symptoms, stop using quetiapine prolonged-release and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Other medicines and Rocoz Prolong
Inform your doctor if you are taking, have taken recently, or may need to take any other medicine.
Do not take Quetiapine Alter if you are using any of the following medicines:
-Some HIV medicines.
-Azole-type medicines (for fungal infections).
-Erythromycin or clarithromycin (for infections).
-Nefazodone (for depression).
Inform your doctor if you are using any of the following medicines:
Before stopping any of your medicines, consult your doctor first.
Taking Rocoz Prolong with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. Do not take quetiapine during pregnancy, unless you have consulted your doctor. Do not use quetiapine if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborn babies of mothers who have used this medicine in the last trimester (last three months of their pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machines
These tablets may make you feel drowsy. Do not drive or operate tools or machines until you know how the tablets affect you.
Rocoz Prolong contains lactose
Rocoz Prolong contains lactose, a type of sugar. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Effect on drug detection tests in urine
If you are having a drug detection test in urine, taking Rocoz Prolong may produce positive results for methadone or certain antidepressant medicines called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but will normally be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
If you take more Rocoz Prolong than you should
If you take more quetiapine than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your Quetiapine Alter tablets with you. You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Rocoz Prolong
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed tablet.
If you interrupt treatment with Rocoz Prolong
If you stop taking quetiapine abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
orBoth men and women experiencing breast swelling and unexpected milk production.
orWomen not having a menstrual period or having irregular periods.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Unknown: the frequency cannot be estimated from available data
The class of medicines to which quetiapine belongs can cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased number of certain types of blood cells, decreased number of red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium levels in the blood, and increased levels of prolactin hormone in the blood. Elevated prolactin levels may, in rare cases, lead to:
Your doctor may ask you to have blood tests from time to time.
Additional side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common: may affect more than 1 in 10 people
orBoth boys and girls experiencing breast swelling and unexpected milk production.
orGirls not having a menstrual period or having irregular periods.
Common: may affect up to 1 in 10 people
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es/. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Rocoz Prolong does not require special conditions for conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of Rocoz Prolong
-The active ingredient is quetiapine. Rocoz Prolong tablets contain 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg of quetiapine (as quetiapine fumarate).
-The other components are:
Tablet core: Copolymer of methacrylic acid and ethyl acrylate (1:1), anhydrous lactose (lactose), crystalline maltose, talc, magnesium stearate
Tablet coating: Copolymer of methacrylic acid and ethyl acrylate (1:1), triethyl citrate
Appearance of Rocoz Prolong and packaging contents
Rocoz Prolong 50 mg tablets are white, round, biconvex, and have "50" engraved on one face
Rocoz Prolong 150 mg tablets are white, oblong, biconvex, and have "150" engraved on one face
Rocoz Prolong 200 mg tablets are white, oblong, biconvex, and have "200" engraved on one face
Rocoz Prolong 300 mg tablets are white, oblong, biconvex, and have "300" engraved on one face
Rocoz Prolong 400 mg tablets are white, oval, biconvex, and have "400" engraved on one face
They are presented in blisters of polychlorotrifluoroethylene and polyvinyl chloride with aluminum
The packaging sizes are:
Rocoz Prolong 50 mg: 10 or 60 tablets
Rocoz Prolong 150 mg: 60 tablets
Rocoz Prolong 200 mg: 60 tablets
Rocoz Prolong 300 mg: 60 tablets
Rocoz Prolong 400 mg: 60 tablets. Some packaging sizes may only be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Laboratorios Alter, S.A.
Mateo Inurria, 30
28036 Madrid
Spain
Responsible manufacturer:
Pharmathen International S.A
Industrial Park Sapes,
Rodopi Prefecture, Block No 5,
Rodopi 69300,
Greece
or
Pharmathen S.A.
Dervenakion 6
Pallini 15351
Attiki,
Greece
Last review date of this leaflet:july 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.